Characterization of Turner Syndrome-associated Diabetes Mellitus
- PMID: 38961758
- PMCID: PMC12012693
- DOI: 10.1210/clinem/dgae357
Characterization of Turner Syndrome-associated Diabetes Mellitus
Abstract
Context: Diabetes mellitus (DM) risk factors in Turner syndrome (TS) may include autoimmunity, obesity, β-cell dysfunction, genetic predisposition, and insulin resistance (IR).
Objective: This work aimed to evaluate glucose tolerance and DM risk factors in adults with TS.
Methods: A single-center study with 2 phases was conducted to determine the prevalence of DM and to assess DM risk markers comparing women with TS with and without impaired glucose tolerance (IGT). The study took place at a tertiary referral center, University College Hospitals. A total of 106 women with TS (age range, 18-70 years) undergoing annual health surveillance underwent oral glucose tolerance tests (OGTTs), with additional samples for autoimmunity and genetic analysis. Main outcome measures included glucose tolerance, insulin, autoimmune, and single-nucleotide variation (SNV) profile.
Results: OGTT screening showed that among those without a previous DM diagnosis, 72.7% had normal glucose tolerance, 19.5% had IGT, and 7.6% were newly diagnosed with DM. OGTT identified more cases of DM than glycated hemoglobin A1c sampling alone. Women with IGT or DM were older, with higher body mass index and IR. No association was found between autoimmune markers glutamic acid decarboxylase (GAD), islet antigen-2, and zinc transporter 8, risk karyotypes, or selected SNVs and DM. In DM cases, GAD positivity was associated with requirement for insulin therapy. The median age of onset of the diagnosis of DM was 36 years (range, 11-56 years).
Conclusion: In the spectrum of DM subtypes, TS-associated DM lies between type 1 and type 2 DM with features of both. Key factors include weight and IR. Assessing C-peptide or GAD antibodies may aid future insulin requirement.
Keywords: SNVs; Turner syndrome; autoimmunity; diabetes mellitus; genetic variability; glucose homeostasis.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society.
Figures

Comment in
-
Turner's Syndrome, Glucagon-like Peptide 1, and Glucose-dependent Insulinotropic Polypeptide Agents: Silver Bullets?J Clin Endocrinol Metab. 2025 Feb 18;110(3):e901-e902. doi: 10.1210/clinem/dgae435. J Clin Endocrinol Metab. 2025. PMID: 38916474 No abstract available.
Similar articles
-
Screening for Turner Syndrome-Associated Hyperglycemia: Evaluating Hemoglobin A1c and Fasting Blood Glucose.Horm Res Paediatr. 2024;97(4):374-382. doi: 10.1159/000534371. Epub 2023 Oct 3. Horm Res Paediatr. 2024. PMID: 37788658 Free PMC article.
-
Increased Prevalence of Beta-Cell Dysfunction despite Normal HbA1c in Youth and Young Adults with Turner Syndrome.Horm Res Paediatr. 2021;94(7-8):297-306. doi: 10.1159/000520233. Epub 2021 Oct 15. Horm Res Paediatr. 2021. PMID: 34657042 Free PMC article.
-
X-chromosome gene dosage and the risk of diabetes in Turner syndrome.J Clin Endocrinol Metab. 2009 Sep;94(9):3289-96. doi: 10.1210/jc.2009-0384. Epub 2009 Jun 30. J Clin Endocrinol Metab. 2009. PMID: 19567529 Free PMC article.
-
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.Acta Diabetol. 2009 Jun;46(2):85-95. doi: 10.1007/s00592-009-0112-9. Epub 2009 Mar 26. Acta Diabetol. 2009. PMID: 19322513 Review.
-
THE DIABETES EPIDEMIC IN CHINA: AN INTEGRATED REVIEW OF NATIONAL SURVEYS.Endocr Pract. 2016 Sep;22(9):1119-29. doi: 10.4158/EP161199.RA. Epub 2016 Jun 13. Endocr Pract. 2016. PMID: 27295015 Free PMC article. Review.
Cited by
-
The Influence of X Chromosome Parent-of-Origin on Glycemia in Individuals with Turner Syndrome.Horm Res Paediatr. 2024 Nov 18:1-9. doi: 10.1159/000542677. Online ahead of print. Horm Res Paediatr. 2024. PMID: 39557026
References
-
- Nielsen J, Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet. 1991;87(1):81‐83. - PubMed
-
- Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner syndrome. Research support, non-U.S. Gov't. J Clin Epidemiol. 1998;51(2):147‐158. - PubMed
-
- Ibarra-Gasparini D, Altieri P, Scarano E, et al. . New insights on diabetes in Turner syndrome: results from an observational study in adulthood. Endocrine. 2018;59(3):651‐660. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical